Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody.
about
Molecular recognition of gangliosides and their potential for cancer immunotherapiesRacotumomab-alum vaccine for the treatment of non-small-cell lung cancer.Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles.Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences.Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis.NGcGM3/VSSP vaccine as treatment for melanoma patients.Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer.Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistancePilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patients.Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.Racotumomab for treating lung cancer and pediatric refractory malignancies.Anti-NeuGcGM3 reactivity: a possible role of natural antibodies and B-1 cells in tumor immunosurveillance.A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells.Human antibodies reactive to NeuGcGM3 ganglioside have cytotoxic antitumor properties.CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.Altered expression of ganglioside GM3 molecular species and a potential regulatory role during myoblast differentiation.Glycosaminoglycans and glycolipids as potential biomarkers in lung cancer.Biological Roles of Aberrantly Expressed Glycosphingolipids and Related Enzymes in Human Cancer Development and Progression.Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3.
P2860
Q26830588-15F44490-133E-47DC-8B00-48ED82BABD5BQ34449304-86E43E00-CBED-4D79-8293-AA75E1183D42Q35217621-26FB56EC-55BF-47E2-BE80-450628430931Q36304631-2143F0C1-96DB-4B41-86E4-2EE20D6DB011Q37393097-D6DF5B64-5DCD-4A96-86D4-8BF66D6E3E4BQ37514743-6C58AE78-9882-4A42-96AF-078661A2EEFFQ37594945-2B653414-DCB8-4039-9143-6D3FAC4157D8Q38195691-17CC605C-6C71-4267-A326-B76EA707D072Q38207923-3D16EB57-34F8-4A11-8C08-B2EA114F95ABQ38285397-D7CCC6EE-0CA3-4316-B54D-C0B819066FA6Q38745411-35954D1E-239D-4FCC-A19C-2D8F4F6AEBAFQ38848896-43F6AAF4-614F-4014-A99A-0303155A61BCQ39172701-429871F1-A730-4D8A-A88D-22D1D8935B7AQ39210534-6B2CF187-D853-4344-8212-A9F11CE5DA38Q42723974-EDB060CB-ABCD-42AB-8D98-FD34AA55EAE9Q46406984-0EF42736-10EC-4448-B746-2D8E74AA3140Q47777414-6A3406FD-3C18-4DC5-820B-FFB4BA329D06Q54943815-5CB91B6B-3760-4FF1-8050-E9C1972DD81DQ55439726-E8336BA4-A375-4E68-B7E9-58237EA352B8
P2860
Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Detection of N-glycolyated gan ...... sing GMR8 monoclonal antibody.
@en
Detection of N-glycolyated gan ...... sing GMR8 monoclonal antibody.
@nl
type
label
Detection of N-glycolyated gan ...... sing GMR8 monoclonal antibody.
@en
Detection of N-glycolyated gan ...... sing GMR8 monoclonal antibody.
@nl
prefLabel
Detection of N-glycolyated gan ...... sing GMR8 monoclonal antibody.
@en
Detection of N-glycolyated gan ...... sing GMR8 monoclonal antibody.
@nl
P2093
P2860
P356
P1433
P1476
Detection of N-glycolyated gan ...... sing GMR8 monoclonal antibody.
@en
P2093
Atsushi Watanabe
Hirofumi Chiba
Hiroki Takahashi
Jinichi Inokuchi
Koji Kuronuma
Motoko Takahashi
Nobuyoshi Hayashi
Shinsei Gasa
Tadashi Hasegawa
P2860
P356
10.1111/CAS.12027
P577
2012-10-30T00:00:00Z